SLC39A14 and acute myeloid leukemia: Cell cycle analysis indicated that the HL-60+SLC39A14-siRNA2 (515) group exhibited inhibitory effects on AML cells in the G1 phase compared to the control group (HL-60+NC-siRNA) (Figure 9A,B).